— Know what they know.
Not Investment Advice
Also trades as: DOCM.SW (SIX) · $vol 6M · ROSE.SW (SIX) · $vol 4M · 0RRB.L (LSE) · $vol 2M

ZRSEF OTC

DocMorris AG
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0%
$10.24
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Distribution · Tech Score Sell · Power 46 · $500.4M mcap · 35M float · 0.0000% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$1.1B +10.6% ▲
5Y CAGR: -5.3%
Gross Profit
$106M -51.2% ▼
5Y CAGR: -15.2%
Operating Income
-$84M +19.1% ▲
Net Income
-$134M -38.3% ▼
EPS (Diluted)
$-2.60 +68.5% ▲
EBITDA
-$39M -4.7% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1.7B$931M$969M$1.0B$1.1B
YoY Growth+16.9%-46.1%+4.1%+4.9%+10.6%
Cost of Revenue$1.5B$1.4B$766M$801M$1.0B
Gross Profit$260M$160M$203M$217M$106M
Gross Margin15.1%17.2%21.0%21.3%9.4%
R&D Expenses$0$0$0$0$0
SG&A Expenses$226M$165M$122M$158M$0
Operating Expenses$153M$120M$114M$321M$190M
Operating Income$107M$40M$90M-$104M-$84M
Operating Margin6.2%4.3%9.3%-10.2%-7.5%
Interest Expense$16M$18M$19M$20M$18M
Income Before Tax-$227M-$169M-$119M-$103M-$122M
Tax Expense-$949K$2M-$1M-$6M$12M
Net Income-$226M-$171M$82M-$97M-$134M
Net Margin-13.1%-18.4%8.5%-9.6%-12.0%
EPS (Diluted)$-23.40$-15.88$-10.07$-8.25$-2.60
EBITDA-$178M-$112M-$56M-$38M-$39M
Shares Outstanding10M11M12M12M52M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms